Epidermolysis Bullosa Pruriginosa Treated With Baricitinib
Author:
Affiliation:
1. Department of Dermatology, Peking University First Hospital, Beijing Key Laboratory of Molecular Diagnosis on Dermatoses and National Clinical Research Center for Skin and Immune Diseases, Beijing, China
Publisher
American Medical Association (AMA)
Subject
Dermatology
Link
https://jamanetwork.com/journals/jamadermatology/articlepdf/2783859/jamadermatology_jiang_2021_lo_210014_1634154568.74023.pdf
Reference6 articles.
1. Prevalence, pathophysiology and management of itch in epidermolysis bullosa.;Papanikolaou;Br J Dermatol,2021
2. Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials.;Simpson;Br J Dermatol,2020
3. Treatment of epidermolysis bullosa pruriginosa-associated pruritus with dupilumab.;Shehadeh;Br J Dermatol,2020
4. Assessment of clinical response to Janus kinase inhibition in patients with familial chilblain lupus and TREX1 mutation.;Zimmermann;JAMA Dermatol,2019
5. Use of epidermal growth factor receptor inhibitor erlotinib to treat palmoplantar keratoderma in patients with Olmsted syndrome caused by TRPV3 mutations.;Greco;JAMA Dermatol,2020
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Beyond the Surface: A Narrative Review Examining the Systemic Impacts of Recessive Dystrophic Epidermolysis Bullosa;Journal of Investigative Dermatology;2024-09
2. Epidermolysis Bullosa Pruriginosa Treated With Upadacitinib;JAMA Dermatology;2024-08-21
3. Real‐world experience of using dupilumab and JAK inhibitors to manage pruritus in epidermolysis bullosa pruriginosa;Skin Health and Disease;2024-08-19
4. Systematic review on antipruritic therapies for patients with Epidermolysis bullosa;Journal of Dermatological Treatment;2024-07-28
5. Epidermolysis Bullosa Pruriginosa treated with baricitinib: A case report;Medicine;2024-07-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3